{
    "clinical_study": {
        "@rank": "43610", 
        "arm_group": {
            "arm_group_label": "Non-small cell lung cancer", 
            "description": "The cohort data of patients with NSCLC will follow up from diagnosis, treatment response and final survival. Fibrocytes will be checked on the date of diagnsis (before treatment), re-staing (3months after treatment) and disease progression."
        }, 
        "brief_summary": {
            "textblock": "The investigators will collect fibrocytes (CD45+Col-1+) in patients with non-small cell lung\n      cancer (NSCLC). The investigators hypothesize that  patients  with  NSCLC experience\n      expansion  of immunosuppressive  fibrocytes,  which  are  predicted  to  augment  tumor\n      growth  by mediating immune escape in NSCLC patients."
        }, 
        "brief_title": "Circulating Fibrocytes in Non-small Cell Lung Cancer.", 
        "completion_date": {
            "#text": "May 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "NSCLC", 
        "condition_browse": {
            "mesh_term": "Carcinoma, Non-Small-Cell Lung"
        }, 
        "detailed_description": {
            "textblock": "Fibrocytes  have  been  described  in  both  mice  and  humans,  where  they  bear  a\n      hematopoietic progenitor phenotype (CD45+Col-1+). Fibrocytes have  previously been described\n      in murine cancer, implicated as mediators of tumor immune escape. In this study, the\n      investigators will collect fibrocytes including CD45+Col-1+ expression. The cells express\n      indoleamine  oxidase,  which  is  primarily  responsible  for  their  immunosuppressive\n      properties.  The investigators hypothesize that  patients  with  non-small cell lung cancer\n      experience  expansion  of immunosuppressive  fibrocytes,  which  are  predicted  to  augment\n       tumor  growth  by mediating immune escape in non-small cell lung cancer patients."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Histologically or cytologically confirmed non-small cell lung cancer (NSCLC).\n\n        Exclusion Criteria:\n\n          -  Combination of other malignancy.\n\n          -  Age less than 20 years (not include 20 years).\n\n          -  Pregnancy."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "N/A", 
            "minimum_age": "20 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "Patients with histologically or cytologically confirmed non-small cell lung cancer (NSCLC)\n        will be enrolled and evaluated from 2013 to 2016. Disease in all cases was staged with\n        computed tomography (CT) of the chest, breast (if resectable) and positron emission\n        tomography (PET, if resectable) within 3 months before enrollment."
            }
        }, 
        "enrollment": {
            "#text": "60", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "November 13, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01998425", 
            "org_study_id": "IRB100-2929B-FibLC-CGMH"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "circulating fibrocytes", 
            "fibrocyte", 
            "NSCLC", 
            "treatment response", 
            "survival", 
            "stage"
        ], 
        "lastchanged_date": "November 24, 2013", 
        "location": [
            {
                "contact": {
                    "email": "vikingchung@yahoo.com.tw", 
                    "last_name": "Fu-Tsai Chung"
                }, 
                "facility": {
                    "address": {
                        "city": "Linkou", 
                        "country": "Taiwan"
                    }, 
                    "name": "Chang Gung Memorial Hospital"
                }, 
                "investigator": [
                    {
                        "last_name": "Fu-Tsai Chung", 
                        "role": "Principal Investigator"
                    }, 
                    {
                        "last_name": "Han-Pin Kuo", 
                        "role": "Sub-Investigator"
                    }, 
                    {
                        "last_name": "Chun-Hua Wang", 
                        "role": "Sub-Investigator"
                    }, 
                    {
                        "last_name": "Yueh-Fu Fang", 
                        "role": "Sub-Investigator"
                    }, 
                    {
                        "last_name": "Ting-Yu Lin", 
                        "role": "Sub-Investigator"
                    }, 
                    {
                        "last_name": "Chih-Teng Yu", 
                        "role": "Sub-Investigator"
                    }
                ], 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "vikingchung@yahoo.com.tw", 
                    "last_name": "Fu-Tsai Chung"
                }, 
                "facility": {
                    "address": {
                        "city": "Taoyuan", 
                        "country": "Taiwan"
                    }, 
                    "name": "Chang Gung Memoral Hospital"
                }, 
                "investigator": [
                    {
                        "last_name": "Fu-Tsai Chung", 
                        "role": "Principal Investigator"
                    }, 
                    {
                        "last_name": "Meng-Heng Hsieh", 
                        "role": "Sub-Investigator"
                    }, 
                    {
                        "last_name": "Horng-Chyuan Lin", 
                        "role": "Sub-Investigator"
                    }, 
                    {
                        "last_name": "Chih-Hsi Kuo", 
                        "role": "Sub-Investigator"
                    }
                ], 
                "status": "Recruiting"
            }
        ], 
        "location_countries": {
            "country": "Taiwan"
        }, 
        "number_of_groups": "1", 
        "other_outcome": {
            "description": "Correlation of circulating fibrocytes and stage of patients with NSCLC.", 
            "measure": "Staging status of patients with NSCLC.", 
            "safety_issue": "No", 
            "time_frame": "18 months"
        }, 
        "overall_contact": {
            "email": "vikingchung@yahoo.com.tw", 
            "last_name": "Fu-Tsai Chung"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Taiwan: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "February 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Correlation of circulating fibrocytes and treatment (chemotherapy, surgery, target treatment) response of patients with NSCLC.", 
            "measure": "treatment response of participants by RECIST.", 
            "safety_issue": "No", 
            "time_frame": "18 months"
        }, 
        "reference": [
            {
                "PMID": "23795584", 
                "citation": "Weng CM, Chen BC, Wang CH, Feng PH, Lee MJ, Huang CD, Kuo HP, Lin CH. The endothelin A receptor mediates fibrocyte differentiation in chronic obstructive asthma. The involvement of connective tissue growth factor. Am J Respir Crit Care Med. 2013 Aug 1;188(3):298-308. doi: 10.1164/rccm.201301-0132OC."
            }, 
            {
                "PMID": "22325070", 
                "citation": "Wang CH, Huang CD, Lin HC, Huang TT, Lee KY, Lo YL, Lin SM, Chung KF, Kuo HP. Increased activation of fibrocytes in patients with chronic obstructive asthma through an epidermal growth factor receptor-dependent pathway. J Allergy Clin Immunol. 2012 May;129(5):1367-76. doi: 10.1016/j.jaci.2012.01.038. Epub 2012 Feb 9."
            }, 
            {
                "PMID": "18583572", 
                "citation": "Wang CH, Huang CD, Lin HC, Lee KY, Lin SM, Liu CY, Huang KH, Ko YS, Chung KF, Kuo HP. Increased circulating fibrocytes in asthma with chronic airflow obstruction. Am J Respir Crit Care Med. 2008 Sep 15;178(6):583-91. doi: 10.1164/rccm.200710-1557OC. Epub 2008 Jun 26."
            }, 
            {
                "PMID": "22174092", 
                "citation": "Chung FT, Lee KY, Wang CW, Heh CC, Chan YF, Chen HW, Kuo CH, Feng PH, Lin TY, Wang CH, Chou CL, Chen HC, Lin SM, Kuo HP. Tumor-associated macrophages correlate with response to epidermal growth factor receptor-tyrosine kinase inhibitors in advanced non-small cell lung cancer. Int J Cancer. 2012 Aug 1;131(3):E227-35. doi: 10.1002/ijc.27403. Epub 2012 Jan 11."
            }, 
            {
                "PMID": "23757729", 
                "citation": "Zhang H, Maric I, DiPrima MJ, Khan J, Orentas RJ, Kaplan RN, Mackall CL. Fibrocytes represent a novel MDSC subset circulating in patients with metastatic cancer. Blood. 2013 Aug 15;122(7):1105-13. doi: 10.1182/blood-2012-08-449413. Epub 2013 Jun 11."
            }, 
            {
                "PMID": "22955317", 
                "citation": "Feng PH, Lee KY, Chang YL, Chan YF, Kuo LW, Lin TY, Chung FT, Kuo CS, Yu CT, Lin SM, Wang CH, Chou CL, Huang CD, Kuo HP. CD14(+)S100A9(+) monocytic myeloid-derived suppressor cells and their clinical relevance in non-small cell lung cancer. Am J Respir Crit Care Med. 2012 Nov 15;186(10):1025-36. doi: 10.1164/rccm.201204-0636OC. Epub 2012 Sep 6."
            }, 
            {
                "PMID": "19572148", 
                "citation": "Liu CY, Wang YM, Wang CL, Feng PH, Ko HW, Liu YH, Wu YC, Chu Y, Chung FT, Kuo CH, Lee KY, Lin SM, Lin HC, Wang CH, Yu CT, Kuo HP. Population alterations of L-arginase- and inducible nitric oxide synthase-expressed CD11b+/CD14\u207b/CD15+/CD33+ myeloid-derived suppressor cells and CD8+ T lymphocytes in patients with advanced-stage non-small cell lung cancer. J Cancer Res Clin Oncol. 2010 Jan;136(1):35-45. doi: 10.1007/s00432-009-0634-0."
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01998425"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "description": "Correlation of circulating fibrocytes and survival (progression free survival, disease free survival and overall survival) of patients with NSCLC.", 
            "measure": "Survival of participants.", 
            "safety_issue": "No", 
            "time_frame": "24 months"
        }, 
        "source": "Chang Gung Memorial Hospital", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Chang Gung Memorial Hospital", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "November 2013", 
        "study_design": "Observational Model: Cohort, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "October 2013"
    }
}